<?xml version="1.0" encoding="UTF-8"?>
<p>The health crisis caused by the novel SARS‐CoV‐2 (formally called 2019‐nCoV)‐related pandemic requires urgent action, including a necessary therapeutic response. Pregnant women are just as exposed as the general population and should not be excluded because of their status, from discussions on effective and well tolerated candidate treatments. While in countries that have opted for national containment, daily non‐emergency medical and surgical activities are suspended, obstetric services continue to operate relentlessly and are experiencing a surge in ‘at‐risk’ pregnancies. Some countries have now recommended routine screening of all pregnant women
 <xref rid="bjo16270-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref>, 
 <xref rid="bjo16270-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> but the low availability and performance of the current tests limit their use.
</p>
